ʻO ka PCR Fluorescence
-
Chlamydia Trachomatis, Ureaplasma Urealyticum a me Neisseria Gonorrhoeae Nucleic Acid
He kūpono kēia pahu no ka ʻike qualitative o nā pathogens maʻamau i nā maʻi urogenital in vitro, me Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), a me Neisseria gonorrhoeae (NG).
-
Herpes Simplex Virus Type 2 Nucleic Acid
Hoʻohana ʻia kēia kit no ka ʻike kūpono o ka herpes simplex virus type 2 nucleic acid i loko o ka swab male urethral swab a me nā hōʻailona cervical cervical swab.
-
Chlamydia Trachomatis Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o Chlamydia trachomatis nucleic acid i loko o ka mimi kāne, ka urethral swab kāne, a me nā mea hoʻohālike o ka wahine cervical swab.
-
Enterovirus Universal, EV71 a me CoxA16 Nucleic Acid
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o enterovirus, EV71 a me CoxA16 nucleic acids i loko o ka puʻu ʻāʻī a me nā ʻano wai o ka herpes o nā mea maʻi me ka maʻi lima-wāwae-waha, a hāʻawi i kahi ala kōkua no ka hōʻoia ʻana o nā mea maʻi me ka lima-wāwae-waha. maʻi maʻi.
-
ʻO ka pale ʻana o ka Mycobacterium Tuberculosis INH
Hoʻohana ʻia kēia kit no ka ʻike pono ʻana i ka hoʻololi ʻana o ka ʻakika amino 315 o ka gene katG (K315G>C) a me ka hoʻololi ʻana o ka ʻāpana o ka mea hoʻolaha o ka gene InhA (- 15 C>T).
-
ʻEono ʻano o ka hanu hanu
Hiki ke hoʻohana ʻia kēia kit e ʻike pono i ka waikawa nucleic o SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae a me respiratory syncytial virus in vitro.
-
Hui B Streptococcus Nucleic Acid
Hoʻohana ʻia kēia kit e ʻike pono i ka hui B streptococcus nucleic acid DNA in vitro rectal swabs, vaginal swabs a i ʻole rectal/vaginal mixed swabs o nā wahine hāpai me nā mea koʻikoʻi nui ma kahi o 35 ~ 37 mau pule o ka hāpai ʻana, a me nā wiki gestational ʻē aʻe me nā hōʻailona maʻi like. e like me ka haki ʻana o nā membrane, hoʻoweliweli i ka hana preterm, etc.
-
AdV Universal a me Type 41 Nucleic Acid
Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o ka adenovirus nucleic acid i loko o nā swabs nasopharyngeal, nā ʻāʻī ʻāʻī a me nā laʻana stool.
-
Mycobacterium Tuberculosis DNA
He kūpono ia no ka ʻike qualitative o Mycobacterium tuberculosis DNA i loko o nā hōʻailona sputum lapaʻau kanaka, a he kūpono ia no ka ʻike kōkua o ka maʻi Mycobacterium tuberculosis.
-
14 HPV Pilikia Ki'eki'e me 16/18 Genotyping
Hoʻohana ʻia ka pahu no ka ʻike PCR qualitative fluorescence-based o nā ʻāpana nucleic acid kikoʻī i nā ʻano papillomavirus 14 (HPV) kanaka (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) i loko o nā pūnaewele exfoliated cervical i loko o nā wahine, a me ka HPV 16/18 genotyping e kōkua i ka ʻike a mālama i ka maʻi HPV.
-
ʻO ka maʻi maʻi maʻi SARS-CoV-2 A influenza B Hui Pū ʻIa Nucleic
He kūpono kēia kit no ka ʻike in vitro qualitative o SARS-CoV-2, influenza A a me ka influenza B nucleic acid o ka nasopharyngeal swab a me nā oropharyngeal swab samples o ka poʻe i manaʻo ʻia i ka maʻi o SARS-CoV-2, influenza A a me ka influenza. B.
-
Nā ʻano like ʻole SARS-CoV-2
Hoʻolālā ʻia kēia pahu i ka ʻike in vitro qualitative o ka coronavirus novel (SARS-CoV-2) ma nā laʻana nasopharyngeal a me ka oropharyngeal swab samples.ʻIke ʻia ka RNA mai SARS-CoV-2 i nā ʻano hanu i ka wā o ka maʻi o ka maʻi a i ʻole ka poʻe asymptomatic.Hiki ke hoʻohana hou ʻia ka ʻike qualitative a me ka ʻokoʻa o Alpha, Beta, Gamma, Delta a me Omicron.
